DK290079A - Fremgangsmaade til fremstilling af prostanoidforbindelser - Google Patents

Fremgangsmaade til fremstilling af prostanoidforbindelser

Info

Publication number: DK290079A
Authority: DK; Denmark
Prior art keywords: procedure; preparation; prostanoid compounds; prostanoid; compounds
Prior art date: 1978-07-11

Application number

DK290079A

Other languages

English (en)

Inventor

E W Collington

H Finch

R F Newton

C J Wallis

Original Assignee

Glaxo Group Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1978-07-11

Filing date

1979-07-10

Publication date

1980-01-12

1979-07-10 Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd

1980-01-12 Publication of DK290079A publication Critical patent/DK290079A/da

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/44—Iso-indoles; Hydrogenated iso-indoles
- C07D209/48—Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C247/00—Compounds containing azido groups
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
- C07C405/0008—Analogues having the carboxyl group in the side-chains replaced by other functional groups
- C07C405/0041—Analogues having the carboxyl group in the side-chains replaced by other functional groups containing nitrogen
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
- C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
- C07C45/68—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
- C07C45/70—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form
- C07C45/71—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form being hydroxy groups
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/44—Oxygen atoms attached in position 4
- C07D211/48—Oxygen atoms attached in position 4 having an acyclic carbon atom attached in position 4
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/10—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms
- C07D295/112—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms with the ring nitrogen atoms and the doubly bound oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
- C07D295/116—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms with the ring nitrogen atoms and the doubly bound oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings with the doubly bound oxygen or sulfur atoms directly attached to a carbocyclic ring
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D295/155—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/10—Oxygen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/10—Oxygen atoms
- C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/94—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems condensed with rings other than six-membered or with ring systems containing such rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/02—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 2
- C07D317/04—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 2 not condensed with other rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
- C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D317/16—Radicals substituted by halogen atoms or nitro radicals

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Hematology (AREA)
Diabetes (AREA)
Pulmonology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Hydrogenated Pyridines (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Pyrane Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
Steroid Compounds (AREA)

DK290079A 1978-07-11 1979-07-10 Fremgangsmaade til fremstilling af prostanoidforbindelser DK290079A (da)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GB7829403		1978-07-11

Publications (1)

Publication Number	Publication Date
DK290079A true DK290079A (da)	1980-01-12

Family

ID=10498352

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK290079A DK290079A (da)	1978-07-11	1979-07-10	Fremgangsmaade til fremstilling af prostanoidforbindelser

Country Status (15)

Country	Link
US (3)	US4265891A (da)
JP (1)	JPS5536475A (da)
AU (1)	AU530907B2 (da)
BE (1)	BE877595A (da)
CH (1)	CH648286A5 (da)
DE (1)	DE2927855A1 (da)
DK (1)	DK290079A (da)
ES (1)	ES482357A1 (da)
FR (1)	FR2430934A1 (da)
IE (1)	IE48907B1 (da)
IT (1)	IT1117403B (da)
NL (1)	NL7905375A (da)
NZ (1)	NZ190966A (da)
SE (1)	SE7906017L (da)
ZA (1)	ZA793452B (da)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ZA81114B (en)	1980-01-09	1982-01-27	Glaxo Group Ltd	Prostanoid compounds and their preparation and pharmaceutical formalation
US4438111A (en)	1980-01-09	1984-03-20	Glaxo Group Limited	Prostanoid compounds and pharmaceutical formulations
AU542949B2 (en) *	1980-01-09	1985-03-28	Glaxo Group Limited	Prostanoid compounds
JPS5718671A (en) *	1980-04-30	1982-01-30	Glaxo Group Ltd	Aminocyclopentane alkenoic acid and esters thereof,manufacture and drug composition
US4371530A (en) *	1980-07-04	1983-02-01	Glaxo Group Limited	Aminocyclopentanone amides and pharmaceutical formulation
NZ197729A (en) *	1980-08-12	1985-03-20	Sanofi Sa	13-oxaprostanoic acid derivatives and pharmaceutical compositions
JPS57183772A (en) *	1981-04-29	1982-11-12	Glaxo Group Ltd	Aminocyclopentanol acids and esters, manufacture and medicinal composition
CA1191134A (en) *	1981-04-29	1985-07-30	Eric W. Collington	Aminocyclopentanol acids and esters and their preparation and pharmaceutical formulation
US4410521A (en) *	1981-09-16	1983-10-18	Glaxo Group Limited	Aminocyclopentane esters and pharmaceutical formulations
IL67041A (en) *	1981-10-29	1988-03-31	Glaxo Group Ltd	2-aminocyclopentane alkanoic and alkenoic acid esters,process for their preparation and pharmaceutical compositions containing them
JPS5973576A (ja) *	1982-09-16	1984-04-25	グラクソ・グル−プ・リミテツド	ピペリジニルシクロペンタノ−ルヘプテン酸塩
GB8307099D0 (en) *	1983-03-15	1983-04-20	Glaxo Group Ltd	Carbocyclic compounds
BE900502A (fr) *	1983-09-06	1985-03-05	Glaxo Group Ltd	Aminocyclopentanes et leur preparation et compositions pharmaceutiques les contenant.
FR2564464B1 (fr) *	1984-05-18	1988-09-02	Glaxo Group Ltd	Ethers aminocyclopentyliques, leur procede de fabrication et composition pharmaceutique en resultant
GB8601985D0 (en) *	1986-01-28	1986-03-05	Glaxo Group Ltd	Chemical process
GB8625322D0 (en) *	1986-10-22	1986-11-26	Glaxo Group Ltd	Chemical compounds
EP0265247B1 (en) *	1986-10-22	1990-08-08	Glaxo Group Limited	Cyclopentyl ethers and their preparation and pharmaceutical formulation
US5039673A (en) *	1987-06-22	1991-08-13	Glaxo Group Limited	Aminocyclopentyl ethers and their preparation and pharmaceutical formulation
US5221695A (en) *	1987-12-22	1993-06-22	Glaxo Group Limited	Aqueous formulation containing a piperidinylcyclopentylheptenoic acid derivative and beta-cyclodextrin
US5169863A (en) *	1988-05-23	1992-12-08	K.K. Ueno Seiyaku Oyo Kenkyujo	Hypersphyxia-causing methods
JPH0566864U (ja) *	1992-02-14	1993-09-03	日立マクセル株式会社	電池パック
US5545665A (en) *	1993-12-28	1996-08-13	Allergan	Cyclopentane(ene) heptenoic or heptanoic acids and derivatives thereof useful as therapeutic agents
US6417228B1 (en) *	1998-11-02	2002-07-09	Alcon Manufacturing, Ltd..	13-Aza prostaglandins for the treatment of glaucoma and ocular hypertension
US6294679B1 (en) *	1999-04-12	2001-09-25	Chirotech Technology Limited	Intermediate for the synthesis of prostaglandins
US20090148527A1 (en) *	2007-12-07	2009-06-11	Robinson Michael R	Intraocular formulation
CN107074678B (zh)	2014-09-08	2020-11-06	昭和电工株式会社	富勒烯衍生物的制造方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB1553293A (en) *	1976-02-23	1979-09-26	Lepetit Spa	Azaprostaglandins
US4189606A (en) *	1976-02-23	1980-02-19	Gruppo Lepetit S.P.A.	13-Azaprostaglandins
IL49325A (en) *	1976-03-31	1979-11-30	Labaz	8-aza-11-deoxy-pge1 derivatives,their preparation and pharmaceutical compositions containing them
US4239778A (en) *	1978-09-12	1980-12-16	The University Of Illinois Foundation	Azaprostanoic acid analogs and their use as inhibitors of platelet aggregation
JPS5718671A (en) *	1980-04-30	1982-01-30	Glaxo Group Ltd	Aminocyclopentane alkenoic acid and esters thereof,manufacture and drug composition
US4371530A (en) *	1980-07-04	1983-02-01	Glaxo Group Limited	Aminocyclopentanone amides and pharmaceutical formulation

1979
- 1979-07-10 AU AU48816/79A patent/AU530907B2/en not_active Ceased
- 1979-07-10 DK DK290079A patent/DK290079A/da not_active Application Discontinuation
- 1979-07-10 CH CH6440/79A patent/CH648286A5/de not_active IP Right Cessation
- 1979-07-10 ES ES482357A patent/ES482357A1/es not_active Expired
- 1979-07-10 US US06/056,416 patent/US4265891A/en not_active Expired - Lifetime
- 1979-07-10 DE DE2927855A patent/DE2927855A1/de not_active Ceased
- 1979-07-10 ZA ZA793452A patent/ZA793452B/xx unknown
- 1979-07-10 NL NL7905375A patent/NL7905375A/xx not_active Application Discontinuation
- 1979-07-10 BE BE0/196216A patent/BE877595A/fr not_active IP Right Cessation
- 1979-07-10 SE SE7906017A patent/SE7906017L/xx not_active Application Discontinuation
- 1979-07-10 IT IT49709/79A patent/IT1117403B/it active
- 1979-07-10 NZ NZ190966A patent/NZ190966A/xx unknown
- 1979-07-10 JP JP8739679A patent/JPS5536475A/ja active Granted
- 1979-07-11 FR FR7917990A patent/FR2430934A1/fr active Granted
- 1979-08-08 IE IE1302/79A patent/IE48907B1/en unknown
1982
- 1982-11-10 US US06/440,622 patent/US4409213A/en not_active Expired - Fee Related
1983
- 1983-07-15 US US06/514,261 patent/US4447428A/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
US4409213A (en)	1983-10-11
BE877595A (fr)	1980-01-10
NL7905375A (nl)	1980-01-15
IT7949709A0 (it)	1979-07-10
ES482357A1 (es)	1980-08-16
US4447428A (en)	1984-05-08
JPH0231061B2 (da)	1990-07-11
IT1117403B (it)	1986-02-17
ZA793452B (en)	1980-06-25
FR2430934A1 (fr)	1980-02-08
AU4881679A (en)	1980-01-17
US4265891A (en)	1981-05-05
IE48907B1 (en)	1985-06-12
CH648286A5 (de)	1985-03-15
DE2927855A1 (de)	1980-03-20
IE791302L (en)	1980-01-11
AU530907B2 (en)	1983-08-04
JPS5536475A (en)	1980-03-14
NZ190966A (en)	1981-10-19
FR2430934B1 (da)	1984-01-13
SE7906017L (sv)	1980-02-13

Publication	Publication Date	Title
DK325079A (da)	1980-02-05	Fremgangsmaade til fremstilling af tiazolidinderivater
DK365079A (da)	1979-08-31	Fremgangsmaade til fremstilling af 1-alfa-hydroxylerede calciferoler
DK156779A (da)	1979-10-19	Fremgangsmaade til fremstilling af cycloalkyltriazoler
DK129879A (da)	1979-10-04	Fremgangsmaade til fremstilling af n-heterocyclyl-4-piperidinaminer
DK290079A (da)	1980-01-12	Fremgangsmaade til fremstilling af prostanoidforbindelser
DK68179A (da)	1979-09-17	Fremgangsmaade til fremstilling af 9-aminodibenzoepyraner
DK266479A (da)	1980-02-04	Fremgangsmaade til fremstilling af 3-aminopropoxyarylderivater
DK303079A (da)	1980-01-27	Fremgangsmaade til fremstilling af imidazolderivater
DK268579A (da)	1980-01-04	Fremgangsmaade til fremstilling af phenetamolaminer
DK77479A (da)	1979-08-26	Fremgangsmaade til fremstilling af penicilliner
DK318079A (da)	1980-01-29	Fremgangsmaade til fremstilling af piperidinforbindelser
DK307279A (da)	1980-01-22	Fremgangsmaade til fremstilling af phenolethere
DK186179A (da)	1979-12-10	Fremgangsmaade til fremstilling af carbapenemderivater
DK265779A (da)	1979-12-27	Fremgangsmaade til fremstilling af o-methallyloxyphenol
DK69479A (da)	1979-08-18	Fremgangsmaade til fremstilling af 2-phenylimino-imidazolidiner
DK433779A (da)	1980-04-14	Fremgangsmaade til fremstilling af phenylquinolizidiner
DK150471C (da)	1987-11-30	Fremgangsmaade til fremstilling af trifluormethylphenoler
DK543079A (da)	1980-06-23	Fremgangsmaade til fremstilling af benzaldehyder
DK58579A (da)	1979-08-14	Fremgangsmaade til fremstilling af hydroxyphenylethere
DK149748C (da)	1987-04-06	Analogifremgangsmaade til fremstilling af n-phenethylacetamidforbindelser
DK145179A (da)	1979-10-08	Fremgangsmaade til fremstilling af 4-methyl-5-hydroxymethyl-imidazol
DK282379A (da)	1980-01-06	Fremgangsmaade til fremstilling af phenylpiperidinderivater isaer substituerede eventuelt enkeltmaettede 1-benzylphenylpiperidiner
DK160281C (da)	1991-07-29	Fremgangsmaade til fremstilling af steroid-s-thioesterderivater
DK239279A (da)	1979-12-11	Fremgangsmaade til fremstilling af 2-oximinophenylacetonitril
DK486079A (da)	1980-05-18	Fremgangsmaade til fremstilling af dihydroxysteroider

Legal Events

Date	Code	Title	Description
1986-04-07	AHB	Application shelved due to non-payment